Publications by authors named "Karine Laud"

12Publications

Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis.

Nucleic Acids Res 2013 Oct 8;41(19):8853-71. Epub 2013 Aug 8.

Institut Curie, 26 rue d'Ulm, 75248 Paris cedex 05, France, INSERM U900, Bioinformatique, biostatistique et épidémiologie d'un système complexe, Paris, France, Mines ParisTech, Fontainebleau, France, INSERM U830, Unité de Génétique et Biologie des Cancers, Paris, France and Institut Curie, Unité de génétique somatique, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gkt678DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799442PMC
October 2013

Oncostatin M is a growth factor for Ewing sarcoma.

Am J Pathol 2012 Nov 13;181(5):1782-95. Epub 2012 Sep 13.

INSERM, UMR, Ligue Team 2012, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2012.07.023DOI Listing
November 2012

EWS-FLI1 inhibits TNFalpha-induced NFkappaB-dependent transcription in Ewing sarcoma cells.

Biochem Biophys Res Commun 2010 Sep 5;399(4):705-10. Epub 2010 Aug 5.

UMR8113 CNRS, LBPA, Ecole Normale Supérieure, Cachan, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2010.08.004DOI Listing
September 2010

Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.

Clin Cancer Res 2010 Apr 6;16(8):2363-74. Epub 2010 Apr 6.

Institut National de la Sante et de la Recherche Medicale UMR_S 957, Université de Nantes EA 3822, Nantes Atlantique Universités, Physiopathologie de la Résorption Osseuse et Thérapie des Tumeurs Osseuses Primitives, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-1779DOI Listing
April 2010

Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer.

Proc Natl Acad Sci U S A 2008 Apr 14;105(16):6004-9. Epub 2008 Apr 14.

Institut National de la Santé et de la Recherche Médicale, Unité 685, Institut Universitaire d'Hématologie, 1, Avenue Claude Vellefaux, 75010 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0710748105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2329709PMC
April 2008

Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees.

Cancer Epidemiol Biomarkers Prev 2005 Oct;14(10):2384-90

Institut National de la Sante et de la Recherche Medicale, Université d'Evry, EMI 0006, Tour Evry 2, 523 Place des Terrasses de l'Agora, 91034 Evry, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-04-0777DOI Listing
October 2005

CDKN2A as a uveal and cutaneous melanoma susceptibility gene.

Genes Chromosomes Cancer 2003 Nov;38(3):265-8

Service de Génétique, Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.10286DOI Listing
November 2003

Mammary leptin synthesis, milk leptin and their putative physiological roles.

Reprod Nutr Dev 2002 Sep-Oct;42(5):399-413

Unité de Recherche sur les Herbivores, Equipe Tissu Adipeux et Lipides du Lait, INRA, 63122 Saint-Genès-Champanelle, France.

View Article

Download full-text PDF

Source
http://rnd.edpsciences.org/articles/rnd/pdf/2002/06/02.pdf
Web Search
http://dx.doi.org/10.1051/rnd:2002034DOI Listing
March 2003